racemetirosine has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khakimova, GR | 1 |
| Degtyareva, EA | 1 |
| Kozina, EA | 1 |
| Kucheryanu, VG | 1 |
| Ugrumov, MV | 1 |
1 other study available for racemetirosine and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
"Provocation test" as a novel approach to early diagnosis of Parkinson's disease.
Topics: alpha-Methyltyrosine; Animals; Dopamine; Early Diagnosis; Enzyme Inhibitors; Locomotion; Male; Mice; | 2015 |